Abstract Publications on diagnosed HIV infection among transgender people have been limited to state-or locallevel data. We analyzed data from the National HIV Surveillance System and present results from the first national-level analysis of transgender people with diagnosed HIV infection. From 2009 to 2014, HIV surveillance jurisdictions from 45 states plus the District of Columbia identified and reported at least one case of newly diagnosed HIV infection for transgender people; jurisdictions from 5 states reported no cases for transgender people. Of 2351 transgender people with newly diagnosed HIV infection during [2009][2010][2011][2012][2013][2014] 84.0% were transgender women (maleto-female), 15.4% were transgender men (female-to-male), and 0.7% were additional gender identity (e.g., gender queer, bi-gender). Over half of both transgender women (50.8%; 1002/1974) and men (58.4%; 211/361) with newly diagnosed HIV infection were non-Hispanic black/African American. Improvements in data collection methods and quality are needed to gain a better understanding of HIV burden among transgender people.
Introduction
''Transgender'' is a comprehensive term for identifying people whose sex assigned at birth does not match their current gender identity or expression [1, 2] . In this study, we use ''transgender woman'' to describe someone who was reported as having a male sex assigned at birth and who currently identifies as a woman, male-to-female (MTF) transgender, transfeminine, or something similar; ''transgender man'' to describe someone who was reported as having a female sex assigned at birth and who currently identifies as a man, female-to-male (FTM) transgender, transmasculine, or something similar; ''additional gender identity'' to describe someone who was reported as having another documented gender identity (e.g., gender queer, bigender); and ''cisgender'' to describe persons with congruence between their sex assigned birth and current gender identity (Table 1) [1, 2] . The National HIV/AIDS Strategy includes transgender populations among those in need of HIV prevention efforts and programs [3] . However, knowledge of actual HIV burden among transgender people in the United States is limited.
In the United States, transgender persons may be disproportionately affected by HIV infection. Among transgender women, the estimated (pooled) HIV prevalence of 21.7% (95% confidence interval 18.4-25.1) is 34 times as high as among other reproductive-age cisgender adults (15-49 years) [4] . In addition, the Centers for Disease Control and Prevention (CDC) reported that during 2013, transgender people had the highest percentage of newly confirmed HIV-positive testing events (1.9% of all HIV testing events), compared to cisgender males (0.9%) and cisgender females (0.2%) [5] .
Reports involving state and city-level HIV surveillance data show that transgender people typically comprise about 1% (range 0.2-2%) of all newly diagnosed HIV infections, AIDS diagnoses, or people living with diagnosed HIV infection [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . However, this percentage is likely to be an underestimate of the true number of transgender people with newly or previously diagnosed HIV in these jurisdictions. Two jurisdictions (Los Angeles County and New York City) have estimated that the number of newly diagnosed cases that they classified as being among transgender people represented approximately half of the actual number of new diagnoses for this population [17, 18] . In 4 of 5 reports from jurisdictions that stratified HIV data by gender identity, 91-100% of transgender people with newly diagnosed or prevalent HIV infection were transgender women [11] [12] [13] [14] 16] .
Researchers have found racial/ethnic disparities in HIV infection among transgender people, with higher percentages for confirmed or self-reported HIV infection among black/African American transgender women compared to transgender women from other racial/ethnic groups. A meta-analysis by Herbst, et [20] . Other researchers have found racial/ethnic disparities for confirmed or self-reported HIV infection among large samples of transgender women from metropolitan areas [13, 21, 22] .
Using qualitative and quantitative methods, researchers have identified several types of HIV-related risk behaviors among transgender people, including multiple sexual partners, unprotected receptive anal or vaginal sex, injecting hormones or drugs and/or sharing syringes and other drug paraphernalia, and commercial sex work [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . Transgender people also experience factors related to stigma and marginalization that may increase their vulnerability to HIV infection, including discrimination and/or victimization, homelessness, incarceration, lack of healthcare insurance or healthcare access, mental health A lack of nationally representative data sources for transgender populations has prompted professional, academic, and federal agencies or organizations to call for improved data collection efforts [47] [48] [49] [50] [51] [52] [53] . The United States Department of Health and Human Services (HHS) has committed to increasing the number of federally funded health and demographic surveys that collect and report sexual orientation and gender identity data and has added an objective to Healthy People 2020 aimed at transgenderspecific data collection [54] [55] [56] . One approach for collecting information on transgender persons is a two-step model, which involves collecting both sex assigned at birth and current gender identify. The two-step model shows high comprehension among transgender survey respondents and compared to a one-question approach, has been shown to result in fewer missing responses and more accurate information [2, 52, 53] . This approach has been used by several national or multi-state data systems, including the CDC's National HIV Surveillance System (NHSS) [5, [57] [58] [59] .
This study is the first to use NHSS data to examine diagnosed HIV infection among transgender people in the United States and describe socio-demographic and HIVrelated characteristics of transgender people newly diagnosed with HIV infection. National-level data on the number and characteristics of transgender people with newly diagnosed HIV infection can inform and guide HIV prevention and treatment efforts for transgender persons in the United States.
Methods
The CDC funds 57 jurisdictions in the United States, including 50 states, the District of Columbia and 6 dependent areas, to collect information on diagnosed HIV infection [60] . Jurisdictions apply document-based surveillance methods and collect information on persons with newly and previously diagnosed HIV infection from various document types, including case reports, laboratory reports, death certificates, birth certificates, and other documents. Jurisdictions report these data void of personally identifying information to the NHSS using a secure data system (the Enhanced HIV/AIDS Reporting System, or eHARS). By 2009, jurisdictions had the option to submit information on current gender identity to CDC using eHARS. During 2011, the fields used to collect information on transgender status were revised, updated in eHARS, and added to the HIV case report form for adults and adolescents (see Current gender identity, defined below). Of the 51 jurisdictions that we evaluated, 46 had identified and reported at least one transgender adult or adolescent with newly diagnosed HIV infection during 2009-2014.
We examined data on newly diagnosed HIV infection from 2009 through 2014 that jurisdictions had reported by June 30, 2016 , excluding data from the 6 United States dependent areas. For adult and adolescent transgender people (C13 years at the time of diagnosis) with newly diagnosed HIV infection during 2009 to 2014, we examined socio-demographic and HIV-related characteristics and calculated HIV case counts and percentages by each characteristic ( Table 2) .
Sex Assigned at Birth
Personnel from jurisdictions collect information on sex assigned at birth from documents such as birth certificates, laboratory reports, medical records, and death certificates. For the NHSS, a hierarchy is applied to select the document with the value that is most likely to accurately represent a person's sex assigned at birth (e.g., birth certificate has highest priority).
Current Gender Identity
Personnel from jurisdictions that collect information on gender identity use data sources such as HIV case report forms submitted by healthcare or HIV testing providers, medical records, or matches with other health department databases (e.g., Ryan White program data). We used information that was collected on HIV case report forms for adults and adolescents with diagnosed HIV infection, excluding data from laboratory reports and other document types. Laboratory personnel generally do not interact with patients and therefore may not have the opportunity to verify an individual's current gender identity. Further, current gender identity is rarely included in other document types (e.g., birth certificates, death certificates). After removing documents with errors (e.g., documents with a value of ''female'' for sex assigned at birth and ''transgender-MTF'' for current gender identity), we examined current gender identity data that were reported to the NHSS on HIV case report forms. Persons with at least one HIV case report form containing a value for current gender identity that differed from the person's sex assigned at birth were considered to be transgender. We used the algorithm presented in Table 1 to assign transgender status and transmission category (described below). 
Diagnoses of HIV Infection
We applied the 2008 revised HIV surveillance case definition, assigning a stage of 1, 2, 3 (AIDS), or unknown to cases based on laboratory evidence [61] . To assign transmission categories for people with diagnosed HIV infection, the CDC uses a hierarchical algorithm that incorporates individual HIV risk factors and assigned sex at birth [62, 63] . Therefore, a transgender woman who had sexual contact with an HIV-infected cisgender male is typically assigned a transmission category of male-to-male sexual contact (MSM). However, for this analysis, we combined the transmission categories of MSM and heterosexual contact into the common category ''sexual contact'', and MSM/injection drug use (IDU) into the common category ''sexual contact/IDU.'' We maintained the original categories of ''IDU'' for people with diagnosed HIV infection attributable to injection drug use, ''other'' for people with diagnosed HIV infection attributable to hemophilia, blood transfusion, or other rare modes of transmission, and ''no identified or reported risk (NIR)'' for people with an unknown transmission category. For facilities where transgender people were initially diagnosed with HIV infection, we used the NHSS categories of inpatient, outpatient, emergency room, screening, diagnostic, or referral site, laboratory, and other/unknown. Screening, diagnostic, or referral sites include facilities that provide HIV counseling and testing services but not ongoing healthcare (e.g., blood bank, drug treatment center, family planning clinic, HIV counseling and testing site, etc.).
Other Socio-demographic Characteristics
To collect information on race/ethnicity, the NHSS applies the Office of Management and Budget guidelines from 1997, which allow the identification of one or more race categories along with Hispanic or Latino ethnicity [62, 64] . We presented both age group and United States region of residence as of the time of diagnosis of HIV infection. Jurisdictions' methods for collecting information on country of birth have been described elsewhere [63] . For vital status, we used information on deaths that jurisdictions reported to the NHSS by June 30, 2016.
Results
Jurisdictions identified and reported 2351 transgender people with newly diagnosed HIV infection during 2009 to 2014, of whom 84.0% were transgender women, 15.4% were transgender men, and 0.7% had an additional gender identity (Table 2 ; data not shown for persons with an additional gender identity). Among 50 states and the 
Discussion
Our analysis is the first to use national surveillance data to explore HIV diagnosis among transgender people. Among transgender people with newly diagnosed HIV during 2009-2014 with data reported to the NHSS, over threequarters were transgender women. This finding is consistent with research involving data from HIV prevention and testing programs, behavioral interventions, and surveys that show high percentages of transgender women with selfreported or diagnosed HIV infection [24, 19] . Comparable literature on HIV infection among transgender men is scarce [65] . We identified 361 transgender men with newly diagnosed HIV during 2009-2014. Our results may be among the first to be reported in the literature that include a large number of transgender men with diagnosed HIV infection in the United States. Similar to Herbst, et al., we found disparities among transgender adults and adolescents with newly diagnosed HIV [19] . Over half of both transgender women and men with newly diagnosed HIV infection during 2009-2014 were black/African American. In their meta-analysis of studies on HIV among transgender populations, Herbst, et al. found the percentage of black/African American transgender women with confirmed HIV infection to be 3 times as high as the percentages for whites or Hispanics or Latinos [19] . We also found that close to half of both transgender women and transgender men resided in the South at the time of their HIV diagnosis. Other reports involving national HIV surveillance data have shown a higher HIV burden for the South, especially among blacks/ African Americans [62, 66, 67] . Among 45 states and the District of Columbia, Georgia and Texas had the third and fourth highest numbers (respectively) of transgender people with newly diagnosed HIV infection during 2009-2014. A combination of factors-including HIV prevalence and the maturity and quality of a jurisdiction's transgender-specific data collection methods-may contribute to these results. Georgia began collecting transgender-specific data during 2008. During recent years, Texas has attempted to improve transgender-specific data collection. California (including the jurisdictions of Los Angeles County and San Francisco) and New York (including the jurisdiction of New York City) where data collection methods have been in place longer than many other states, had the first and second highest percentages (respectively) of newly diagnosed HIV cases for transgender people among the 45 states and the District of Columbia.
To assign transmission categories to cases of newly diagnosed HIV infection, we used an alternate method and collapsed NHSS transmission categories into broader ones. Had we used the standard categories, 86.0% of transgender women would have been described as having HIV attributable to male-to-male sexual contact and 7.5% as having HIV attributable to male-to-male sexual contact and injecting drugs; 34.1% of transgender men would have been described as having HIV attributable to heterosexual contact (i.e., sex with a man previously diagnosed with or at high risk for HIV). For transgender men, we found that over half had no identified or reported risk (compared to 4.9% for transgender women). Researchers have identified factors such as sex, age, birth country, facility type at diagnosis, race/ethnicity, region of residence, and vital status as contributing to higher NIR percentages [63] . To identify potential reasons for the discrepancy in NIR percentages between transgender men and transgender women, we would need to perform additional analyses to examine such factors and further evaluate jurisdictions' methods for collecting and reporting HIV risk factor and transmission category data for transgender men.
One of the goals of both the National HIV/AIDS Strategy and Healthy People 2020 is to reduce the proportion of persons with a diagnosis of HIV infection, stage 3 (AIDS) within 3 months of diagnosis of HIV [3, 56] . We found that for both transgender women and men, less than one-quarter were classified as stage 3 (AIDS) within 3 months of diagnosis. Using NHSS data from the same time period, the CDC found that approximately one-quarter of annual infections overall were classified as stage 3 at the time of diagnosis [68] . Although data from the CDC report are based on sex assigned at birth and therefore include transgender people among the percentages for men and women, these percentages would not be greatly impacted by the exclusion of transgender people given their comparatively small number of diagnoses.
Our analysis is subject to the following limitations. These data may not represent the entire population of transgender people in the United States with newly diagnosed HIV during 2009-2014. Instead, they are limited to cases of newly diagnosed HIV that jurisdictions identified and reported to the NHSS and that could be classified as transgender using an algorithm (Table 1) . Diagnosed HIV among transgender populations may be vastly underreported or misclassified due to data collection challenges for jurisdictions, including correctly identifying current gender identity from documentation in medical records and other data sources [16, 17, [69] [70] [71] . Also, some transgender people may not identify as transgender in healthcare settings due to fear of discrimination or because of previous negative experiences [41] . Errors during documentation on HIV case report forms or data entry could lead to misclassification of transgender status in NHSS data, which could increase or decrease the number of persons apparently transgender (compared to cisgender) or transgender man (compared to transgender woman). Our exclusion of data from laboratory reports may have affected our estimate of the number of transgender people with newly diagnosed HIV infection. Information on current gender identity has not been consistently captured in electronic or paper laboratory reports. Whether to include data from laboratory reports and other documents when classifying transgender status should be reassessed when data collection methods and data quality have improved for these sources.
We applied an algorithm that classified as transgender anyone with at least one HIV case report that included a value of current gender identity that differed from sex assigned at birth. Our algorithm incorporates feedback from jurisdiction-level personnel, who suggested that once a person is classified as transgender, the person should maintain this classification in surveillance data regardless of current gender identity values from subsequent reports. A person's gender identity and expression is fluid and may vary over time. However, the likelihood of someone identifying as transgender followed by cisgender seems more likely to be associated with errors in data collection or data entry, and/or by non-ascertainment of transgender identity at a given provider or facility, than with an actual change from transgender to cisgender identity. The methods used to classify transgender status among persons with diagnosed HIV infection should continue to be evaluated and improved.
As previously mentioned, jurisdictions with transgenderspecific data collection methods in place for longer time periods may have more accurate data. Socio-demographic characteristics may be different for transgender people with newly diagnosed HIV who reside in states other than those we included in our analysis. Also, we excluded data for people with an additional gender identity, who comprised \1% of the study population and had small cell sizes.
Despite the limitations, our findings have several important implications for HIV prevention and care efforts and surveillance activities. First, we performed the first analysis of national surveillance data for transgender people with newly diagnosed HIV infection, providing results that can be used to supplement other analyses on HIVrelated risk behaviors and/or transmission categories for transgender people [5, 20, 57, 67, 72] . Second, racial and regional disparities are evident. Those who develop or implement HIV prevention and care programs should consider these disparities and tailor programs to the needs of transgender people. Third, HIV surveillance programs that do not currently have practices in place for collecting transgender-specific data should develop and implement such practices and continue to evaluate and improve upon them. Fourth, developing practices for capturing information from electronic and paper laboratory reports is essential to gaining a more complete picture of diagnosed HIV infection among transgender adults and adolescents. Finally, as national transgender population estimates become available, calculating HIV disease burden (e.g., HIV prevalence and diagnosis rates) among transgender people will become a reachable goal. Adequate population estimates have been published [73] . However, standard population estimates from the United States Census Bureau are unavailable, and further improvements to the quality of HIV surveillance data at the national and jurisdiction levels are needed [74] .
In summary, our results showed a higher percentage of newly diagnosed HIV infection among transgender women than transgender men. Racial and regional disparities are evident. Improvements to data collection methods and data quality are needed. National and local agencies and providers serving transgender populations should tailor HIV prevention and treatment programs to be accepting of a person's stated gender identity and be sensitive to the unique healthcare needs of transgender people living with HIV.
